Fiocruz

06.01.2025 • News

GemmaBio Secures $34 Million in Funding

Gemma Biotherapeutics (GemmaBio), a new therapeutics company founded by gene therapy pioneer Jim Wilson, recently announced the completion of a $34 million seed funding round to accelerate its groundbreaking gene therapy initiatives.

06.06.2014 • Topics • Strategy

Opportunities Through Biotechnology

Top-Feature

Ecocool GmbH

Transport Logistic: Ecocool Presents Packaging Solutions for Pharmaceutical Transports

IMCD Deutschland GmbH

Fostering Innovation and Collaboration

Evonik Industries AG

Maximize the Potential of Spent Hydroprocessing Catalysts

Digitalization in the chemical industry

Free Virtual Event

Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Gemma Biotherapeutics

Thomson Reuters